Valuation: Lifecare ASA

Market Cap 87.65M 9.15M 8.03M 7.47M 6.86M 12.88M 881M 13.08M 88.73M 34.67M 433M 34.34M 33.6M 1.5B P/E 2026 *
-0.77x
P/E 2027 * -1.05x
Enterprise Value 124M 12.91M 11.33M 10.54M 9.67M 18.17M 1.24B 18.45M 125M 48.9M 611M 48.45M 47.4M 2.11B EV / Sales 2026 *
-
EV / Sales 2027 * 25.1x
Free-Float
89.66%
Yield 2026 *
-
Yield 2027 * -
1 day-4.56%
1 week-4.56%
Current month-14.78%
1 month-14.78%
3 months-31.93%
6 months-59.64%
Current year-92.94%
1 week 0.28
Extreme 0.2825
0.28
1 month 0.28
Extreme 0.2825
0.3
Current year 0.28
Extreme 0.2825
0.9
1 year 0.28
Extreme 0.2825
18.1
3 years 0.28
Extreme 0.2825
18.1
5 years 0.28
Extreme 0.2825
18.1
10 years 0.28
Extreme 0.2825
18.1
Manager TitleAgeSince
Chief Executive Officer 50 07/09/2020
Director of Finance/CFO - 01/04/2026
Corporate Officer/Principal - 01/03/2024
Director TitleAgeSince
Director/Board Member - 26/06/2020
Chairman - 08/05/2021
Director/Board Member - 20/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-4.56%-4.56% - - 9.2M
+1.07%-4.73%-3.96%+11.63% 46.35B
+0.25%+1.65%+408.41%+629.49% 40.13B
-0.27%+4.45%+9.93%+66.92% 36.33B
+0.35%+0.87%+3.60%-8.81% 34.6B
+3.14%+1.02%+3.72%+34.86% 26.77B
+0.47%-2.74% - - 16.66B
-0.73%+11.84%+31.97%+143.53% 16.91B
+0.42%-4.46%+4.80%+8.67% 13.05B
-2.68%-2.49%-15.00%-31.68% 13.05B
Average -0.26%+1.02%+55.43%+106.83% 27.09B
Weighted average by Cap. +0.44%+0.77%+75.70%+136.39%

Financials

2026 *2027 *
Net sales - 5M 522K 458K 426K 391K 735K 50.26M 746K 5.06M 1.98M 24.71M 1.96M 1.92M 85.43M
Net income -86M -8.98M -7.88M -7.33M -6.73M -12.64M -864M -12.84M -87.06M -34.01M -425M -33.7M -32.97M -1.47B -82M -8.56M -7.52M -6.99M -6.41M -12.05M -824M -12.24M -83.01M -32.43M -405M -32.13M -31.44M -1.4B
Net Debt 36M 3.76M 3.3M 3.07M 2.82M 5.29M 362M 5.37M 36.44M 14.24M 178M 14.11M 13.8M 615M 38M 3.97M 3.48M 3.24M 2.97M 5.59M 382M 5.67M 38.47M 15.03M 188M 14.89M 14.57M 649M
Logo Lifecare ASA
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Employees
25
Date Price Change Volume

Annual profits - Rate of surprise